Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

Subroutines are usually small in size, which means they are much easier to write, test and debug. They are also easy for someone else to understand. As they are written outside of the main program, ...

Clip: Is the world more dangerous after the Iran war? Iran appears to be significantly degraded as a military power, but its agreement with the U.S. could open new revenue streams for the regime. The ...